Objective: To discuss possible causes of disparities in incidence and mortality rates of ovarian cancer, uterine cancer and cervical cancer between two diverse populations from east and west Asia Methods: Incidence and mortality data from 1999 to 2013 were extracted from Korean and Israeli cancer registries. Age-standardized rates and annual percent changes were calculated. Trends were analyzed using Joinpoint analysis and discussed with respect to risk factor exposure. Results: Age-standardized rate of ovarian cancer significantly increased in Korea (annual percent change 1.7%) but decreased among Jews (annual percent change −2.15%). Age-standardized rate of uterine cancer increased among both Koreans and Israeli Jews (annual percent changes 5.8 and 1.17%, respectively). Incidence of cervical cancer significantly decreased in Korea (annual percent change −3.8%) while remained stable on Israel. Mortality trends paralleled incidence trends with a significant increase in ovarian cancer and uterine cancer mortality in Korea (annual percent changes 1.2 and 4.6%, respectively) and a drop in cervical cancer mortality from 2002 (annual percent change −5.8%). Among Israeli Jews, uterine cancer mortality increased (annual percent change 1.01%), while ovarian cancer mortality decreased (annual percent change −0.58%). Uterine cancer mortality among Arabs declined (annual percent change −0.5%), while cervical cancer mortality remained unchanged. Conclusions: Gynecologic malignancies show different incidence trends in Korea and Israel. Uterine cancer is rising in both countries and is correlated to changing trends in obesity and dietary habits. Ovarian cancer is rising in Korea but declining among Israeli Jews along with changes in parity, © The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 884 childbearing age, contraceptive use and increasing awareness to BRCA gene carriers and risk reduction salpingo-oophorectomy. Cervical cancer is declining in Korea along with an effective screening program implemented. Mortality trends follow incidence trends in both countries
Introduction
Comparing gynecologic cancer incidence and mortality trends between populations of different origins can be a useful tool to assess changes in environmental factor that affect cancer incidence, to monitor the effectiveness of national prevention, screening and early detection programs and to evaluate quality of medical care that affects cancer survival. This information could be useful in cancer control policy planning. For this comparison, we chose two very diverse Asian countries, one in east Asia, South Korea and one in west Asia, Israel. South Korea and Israel, on the one hand, share many similarities that could affect gynecologic cancer incidence and mortality. Both are developed countries and members of the organization for economic co-operation and development (OECD), both have advanced national health systems, with a mandatory national health insurance coverage for all citizens, and both spend comparable percentage of their gross domestic product on health (7.4% during 2014) (1) . On the other hand, women in both countries have different susceptibility to gynecologic cancer, both as a result of their very different genetic background but also as a result of major differences in life styles, dietary, sexual and childbearing habits that are well known to affect gynecologic cancer incidence. Factors which are of particular importance to ovarian cancer (OC) and uterine cancer (UC) incidence include total number of pregnancies, breastfeeding and oral contraceptive use (2) , while cervical cancer (CC) is associated mainly with human papilloma virus exposure and PAP screening. In this report, we sought to compare the recent incidence and mortality trends of the three major gynecological malignancies including OC, CC and UC between these two diverse populations in recent years between 1999 and 2013 and to discuss possible causes of such differences with respect to sociodemographic differences, risk factors exposure and risk reduction programs in the two countries.
Materials and methods
This work was approved by the local IRB. Data on incidence of gynecologic cancer was collected from respective cancer registries, the Korean Central Cancer Registry (KCCR) and the Israeli national cancer Registry (INCR). KCCR was initiated as a hospital-based cancer registry in 1980 and was later expanded to cover the entire population (3). The INCR was established in 1960 and reporting was made mandatory by all in 1980. INCR covers the entire Israeli population and data completeness is estimated at 95-96% for solid tumors (4) . Site and cancer morphology were established according to ICD-O-3 coding manual (5) . Korean mortality data were obtained from the World Health Organization mortality database (6) . Israeli mortality data were obtained from the Israel central bureau of statistics (ICBS) which collects mortality data for the entire Israeli population. As of 1965, reporting to ICBS is mandatory (7). Causes of death are classified according to the ICD 10 (8). For Israeli population, incidence calculations were done for Jews and Arabs separately as these represent very diverse populations. Age-standardized rates (ASRs) per 100 000 people were calculated using the 'Segi World standard population' (9) . Trends in gynecologic cancer incidence were calculated using annual percent changes (APCs) according to SEERs' algorithm with the following formula [Exp (B) − 1] × 100. B was calculated by linear regression of ASR in a given year (10) . APC calculations were also done for age-specific data in order to investigate the relative contribution of each age group to the general trend in each country. In order to avoid LAN function on the number 0, in years where the incidence rate of a specific age subgroup was zero, the number was replaced by 0.00001. Mortality rates are also shown as ASR with APC calculations. Sociodemographic data on factors that might affect cancer incidence in the two countries were obtained from different web resources of epidemiological data from respective countries. Statistical analysis was done using excel spreadsheet ( 
Results

Sociodemographic factors
Major sociodemographic differences between South Korea and Israel are summarized in Table 1 . Sociodemographic data from Korea show an increasing rate of nuliparity, low total fertility rate, reaching 1.2 children per woman, a rising age at both first marriage and first childbirth, the later, averaging 30 years during 2010, a decreasing intake of oral contraceptive use from 1976 to 2006 and a breastfeeding rate that has also decreased dramatically from 90% in 1970 to 24% in 2006 (12, 13) . As opposed to Korea, data from Israel show a much higher fertility rate reaching 3.1 children per woman, age at the first childbirth has not shifted much in the past years and rose from 26 in 1995 to 28 in 2010 and a higher rate of reported oral contraceptive use with over 60% of Israeli women aged 21-44 reporting of ever using oral contraceptives (14) . Moreover, rate of breastfeeding, which is actively encouraged by healthcare programs in Israel, has also increased with as much as 25% of Jewish women and 37% of Arab women that still breast feed 1 year after delivery (15) . Data regarding obesity, which one of the most important risk factors specifically for UC, show that only 5% of Korean women are obese (defined as BMI > 30) compared Age-standardized rates ASR per 100 000 and APCs are shown in Table 2 and Figure 1 . Ovarian cancer ASR: OC ASR significantly increased in Korea from 5.0 to 6.1 (APC 1.7%, 95% CI 1.30-2.20). At the same period in Israel, OC ASR significantly decreased among Jews from 9.63 to 7.67 (APC −2.15%, 95% CI −2.9 to −1.4) while showing no significant change among Arabs 4.14 to 5.03 (APC 1.96%, 95% CI −1.6 to 5.6).
Uterine cancer ASR: UC ASR significantly increased among Koreans and Israeli Jews from 2.8 to 5.9 (APC 5.8%, 95% CI 5.12-6.45) and from 12.83 to 14.67 (APC 1.17%, 95% CI 0.3-2.03), respectively, while remaining stable among Arabs (APC 0.06%, 95% CI −1.7 to 1.9).
Cervical cancer ASR: In Korea, CC ASR significantly decreased from 16.3 to 9.6 (APC −3.8%, 95% CI −4.25 to −3.44) while showed no significant change among Israeli Jews or Arabs (APC 0.53%, 95% CI −0.3 to 1.4, APC 1.01%, 95% CI −3.1 to 5.3, respectively).
Overall ASR: Added together, ASR for all gynecologic malignancies in Korea significantly decreased from 24.1 to 21.5 with an APC of −0.8% (95% CI −1.05 to −0.46). In Israel, overall ASR did not significantly change among Jews (27.43-27.41, APC −0.026, 95% CI −0.56 to 0.51) or Arabs (20.46-20.61, APC 0.54, 95% CI −1.3 to 2.4).
Age-specific incidence rates
Age-specific incidence rates are shown in Supplementary data, Tables 2.1-3, APCs are shown in Figure 2 . A significant increase is seen in OC ASR in Korea across four age groups including, 40-49 (APC 2.6%), 50-59 (APC 1.85) and 70+ (APC 0.6%). In Israel, an opposite trend is seen among Jewish women, with a significant decrease in ASR from age 40 and over in all age group (40-49: APC −2.44%, 50-59: APC −2.82%, 60-69: APC −1.58% and 70+: APC −2.2%). No significant change is seen in any age group among Arabs. UC ASR in among Korean women show an increase across all age groups, with the highest APC in the youngest age group <30 (APC 7.0%). Among Jewish Israeli women, a significant increase in ASR of UC in seen in the older age groups 60-69 and 70+ (APC 1.88 and 1.67%, respectively). Among Arabs, no significant change in ASR of UC was observed in any age group. CC ASR significantly decreased in Korea among all age groups with the exception of the youngest age group <30 years that showed a significant increase with an APC of 3.6% (95% CI 2.2-5.1). In Israel, no significant change in ASR of CC was recorded in any age group among Jews or Arabs.
Mortality
Mortality ASRs are shown in Table 3 and Figure 1 . APC calculations using Joinpoint analysis are shown in Table 4 . In Korea, mortality rates of overall gynecologic malignancies showed a significant decrease from 2001 to 2013 (APC −2.3%, 95% CI −2.7 to −1.9), with a decrease in CC mortality ASR during the same years (APC −5.8, 95% CI −6.6 to −5.1). OC and uterine mortality increased significantly from 1999 to 2013 (APC 1.2%, 95% CI 0.5-1.9 and APC −4.6%, 95% CI 3-6.1, respectively). Changes in mortality in Israel did reach statistical significance between 1999 and 2013 among Jews or Arabs.
Discussion
The aim of our study was to compare incidence and mortality trends of the three major gynecologic malignancies including OC, UC and CC among different Asian countries and to correlate these differences to major sociodemographic shits that may affect gynecologic cancer incidence in the two countries. As South Korea and Israel have many similarities in their national health systems, they were chosen for this comparison. Identifying differences in risk factors associated with each malignancy may help explain the disparities seen in cancer incidence and can assist targeting efforts and implementing cancer prevention policies where most needed.
Cervical cancer: Even though the ASR of CC in Korea is almost double the one seen in Israel during 2013, when comparing trends of CC incidence, the most striking difference is the rapid decline of CC incidence in Korea, compared with the stable incidence observed in Israel during the same period (Figure 1) .
In our opinion, the major factor that may account for these trend differences is the disparity seen in the uptake of PAP screen between the two countries ( Table 1) . In Korea, a very effective national PAP screening program has been implemented, causing a sharp increase in screening rates (18) (19) (20) . The data regarding the uptake of CC screening in Korea shows a steady increase from 2004 to 2012 reaching 67.9% of women who undergo screening as recommended. The low-income subpopulation in Korea, which has the highest risk of CC, showed the most significant increase in uptake of screening, from 42% to 65% of women (20) . Further support as to the importance and effectiveness of PAP screening is given by the finding that the only subpopulation that had an increase in CC incidence in Korea is the young age group <30 years ( Figure 2 ). This age group had the lowest PAP screen uptake (20) along with increased prevalence of HPV infection in more recent Korean birth cohorts (19) . As opposed to Korea, in Israel no national PAP screen program exists and screening is opportunistic. As a result, screening uptake is low and estimated at 15-30% of the Israeli population and case fatality is high, as without screening, diagnosis is often late (21, 22) . Furthermore, stage distribution at the time of diagnosis is different between Korea and Israel, with a much higher percent of Korean patients that are diagnosed at lower stages than that seen in Israel. In recent years, 61.7% of CC patients in Korea are diagnosed at stage 1 compared with 47% in Israel, 29% at stage 2 compared with 18% and 10% at stages 3 and 4 compared with 13.4% in Israel (23, 24) . The decline in incidence seen in Korea causes a direct decline in mortality from CC from 2002 to 2013 with an APC of −5.8% (Figure 1) , with the exception of the young age < 30 that along with the increasing incidence seen in our study, showed a parallel increase in mortality. In Israel, where CC incidence is stable, mortality remained unchanged. In both countries, HPV vaccination was introduced into clinical practice. In Israel, a nationwide vaccination at the age 12 was introduced in 2012 (25) and in Korea during 2016 (26) . Future data should reveal the efficacy of this vaccine among populations with highly different incidences.
Uterine cancer: Incidence of UC is increasing in Korea and in Israel. During the study years, Korean women showed the most significant increase with a 110% relative increase in ASR and an APC of 5.8%. Israeli Jews showed a significant 14% relative increase in ASR and a milder APC increase of 1.17%, (Table 2, Figure 1) . The incidence increase in Korea was seen across all age groups, while among Israeli Jews, a significant increase was seen mainly in the older age groups above 60 (Figure 2) .
One of the major risk factors that could account for the trends in UC incidence is obesity. Data on obesity from countries of the OECD show doubling of obesity rates in Korea (defined as BMI of >30), reaching over 5% of Korean adults with 32% of the population defined as overweight (BMI > 25) (27) . In Israel, data from ICBS show a 17% increase in incidence of obesity among Israeli Jewish women from 2004 to 2011, with a 7% decrease in rate of obesity among Arab women (28) in whom ASR was almost unchanged (Table 2) . Increasing BMI was previously described to be strongly correlated with endometrioid uterine adenocarcinoma among Korean women (29) . Likewise, US-born Asian women, who are exposed to Western diet and lifestyle, are more likely to be diagnosed with endometrioid adenocarcinoma than their Asian counterparts that immigrated to the USA (30) .
Mortality from UC in Korea paralleled the incidence change with a significant APC increase of 4.6% (Table 4, Figure 1) . At the same period in Israel, where incidence of UC showed a milder increase, mortality among Jews showed a non-significant increase with APC of 1.01%, with a non-significant decline in mortality from UC from 2000 to 2013 among Arabs. Even though endometrial cancer is usually diagnosed at an early stage and prognosis is good (31), the increase in mortality observed in Korea could be explained by the very significant rise in its incidence.
Projected OECD data indicate continually rising obesity rates that may reach 9% in Korea by 2030 (27) along with a risk of further increase in UC incidence that may approach the one seen in Israel. As no effective methods is known to prevent UC, emphasis should be directed both at reducing risk factors, as well as to public education of women and primary caretakers regarding alarming symptoms such as postmenopausal bleed that could potentially enable early diagnosis.
Ovarian cancer: Incidence of OC showed opposite trends in Korea and Israel during the study period. In Korea, a significant 22% ASR increase from 1999 to 2013 was noted, while among Israeli Jews a 25.5% decrease in ASR of OC occurred during the same period (Table 2, Figure 1 ). In both Koreans and Israeli Jews, the age groups responsible for these trends are those above 40 years ( Figure 2) .
The total number of ovulatory cycles which is in turn affected by the number of pregnancies, length of breastfeeding and oral contraceptive use is one of the most important risk factors for OC (2). Major sociodemographic shifts in Korea including the increasing rate of nulliparity among Korean women along with low total fertility rate, rising age of the first childbirth, decreasing oral contraceptive decreasing rate of breastfeeding (Table 1 ) (4,32) are correlated to the increasing incidence of OC in Korea. As opposed to Korea, the opposite trend of OC incidence in Israel may be related to opposite sociodemographic trends such as a much higher fertility rate (3.1 children per woman) (33) , age at the first childbirth that only slightly shifted in the past years, higher rate of oral contraceptive use (33) and an increasing rate of breastfeeding that is much encouraged in Israel (34). The decreasing incidence of OC in Israel could also be explained, at least to some extent, by the increasing awareness to BRCA gene screening. Reported prevalence of BRCA mutation carrier in the general Ashkenazi population is as high as 2% in Israel (35) and risk reduction salpingo-oophorectomy (RRSO) in a high-prevalence population could have an effect on OC incidence. Several centers for follow-up and treatment of BRCA mutation carriers have been set up across Israel with the hope of offering effective and accessible preventive medicine for these patients. In Korea, awareness to BRCA gene is high (36) , prevalence of BRCA mutation carrier state among OC patients was reported to be 13.5% rising to 40-60% with positive a family history (37, 38) and the effect of RRSO on OC incidence should be evaluated in the future. Mortality from OC is paralleled to changes in incidence. Rising incidence in Korea is met by a significant rise in mortality, where declining incidence in Israeli Jews is met by a decline in mortality (albeit not significant, Figure 1) . Data from the USA show very similar trends to the one seen among Israeli Jews with a 23% decline in incidence of OC from 1991 to 2011 and an 18% decline in mortality from 2001 to 2011 (39) . The decline in mortality is best accounted for by the decline in incidence, as case fatality, even in the face, of the evolving treatment strategies of OC, have hardly changed (39, 40) . The low birth rate in Korea which may affect the incidence of OC is more of a sociological phenomenon than a medical one, and so decreasing the incidence of OC in Korea may be accomplished by other means such as chemoprevention or encouraging breastfeeding. Moreover, epidemiological research in Korea can clarify further the rate of BRCA carrier state in breast and OC patients as well as in the general population and may enable increasing the rate of preventive measures for BRCA carriers.
Conclusion
Gynecologic malignancies show different incidence trends in Korea and Israel. UC incidence is rising in both countries and is correlated mainly to changing trends in obesity and dietary habits in aging populations. OC incidence is rising in Korea but declining among Israeli Jews, changes that could be explained by changing trends in parity, childbearing age and contraceptive use along with increasing awareness to BRCA gene carriers and RRSO. CC is markedly declining in Korea but remains stable in Israel, owing to an effective screening program implemented in Korea. Mortality trends parallel incidence trends in both countries.
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